Global Drug Discovery and Development Services Market Research Report 2025

Publication ID:

PB504252477

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Drug Discovery and Development Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drug Discovery and Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Discovery and Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Discovery and Development Services in Pharmaceutical and Biological Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Discovery and Development Services include IQVIA, WuXi AppTec, alvern Panalytical锛圫pectris锛�, Sygnature Discovery, RTI International, Genesis Biotechnology Group, Eurofins DiscoverX, Dalton Pharma Services, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery and Development Services.
The Drug Discovery and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
WuXi AppTec
alvern Panalytical锛圫pectris锛�
Sygnature Discovery
RTI International
Genesis Biotechnology Group
Eurofins DiscoverX
Dalton Pharma Services
Segment by Type
Macromolecular Drug
Small Molecule Drug
Segment by Application
Pharmaceutical and Biological Companies
Academic Institution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Macromolecular Drug
1.2.3 Small Molecule Drug
1.3 Market by Application
1.3.1 Global Drug Discovery and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biological Companies
1.3.3 Academic Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery and Development Services Market Perspective (2020-2031)
2.2 Global Drug Discovery and Development Services Growth Trends by Region
2.2.1 Global Drug Discovery and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery and Development Services Market Dynamics
2.3.1 Drug Discovery and Development Services Industry Trends
2.3.2 Drug Discovery and Development Services Market Drivers
2.3.3 Drug Discovery and Development Services Market Challenges
2.3.4 Drug Discovery and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery and Development Services Players by Revenue
3.1.1 Global Top Drug Discovery and Development Services Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Drug Discovery and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery and Development Services Revenue
3.4 Global Drug Discovery and Development Services Market Concentration Ratio
3.4.1 Global Drug Discovery and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery and Development Services Revenue in 2024
3.5 Global Key Players of Drug Discovery and Development Services Head office and Area Served
3.6 Global Key Players of Drug Discovery and Development Services, Product and Application
3.7 Global Key Players of Drug Discovery and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery and Development Services Breakdown Data by Type
4.1 Global Drug Discovery and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery and Development Services Forecasted Market Size by Type (2026-2031)
5 Drug Discovery and Development Services Breakdown Data by Application
5.1 Global Drug Discovery and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery and Development Services Market Size (2020-2031)
6.2 North America Drug Discovery and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery and Development Services Market Size by Country (2020-2025)
6.4 North America Drug Discovery and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery and Development Services Market Size (2020-2031)
7.2 Europe Drug Discovery and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery and Development Services Market Size by Country (2020-2025)
7.4 Europe Drug Discovery and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery and Development Services Market Size (2020-2031)
9.2 Latin America Drug Discovery and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery and Development Services Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Drug Discovery and Development Services Introduction
11.1.4 IQVIA Revenue in Drug Discovery and Development Services Business (2020-2025)
11.1.5 IQVIA Recent Development
11.2 WuXi AppTec
11.2.1 WuXi AppTec Company Details
11.2.2 WuXi AppTec Business Overview
11.2.3 WuXi AppTec Drug Discovery and Development Services Introduction
11.2.4 WuXi AppTec Revenue in Drug Discovery and Development Services Business (2020-2025)
11.2.5 WuXi AppTec Recent Development
11.3 alvern Panalytical锛圫pectris锛�
11.3.1 alvern Panalytical锛圫pectris锛� Company Details
11.3.2 alvern Panalytical锛圫pectris锛� Business Overview
11.3.3 alvern Panalytical锛圫pectris锛� Drug Discovery and Development Services Introduction
11.3.4 alvern Panalytical锛圫pectris锛� Revenue in Drug Discovery and Development Services Business (2020-2025)
11.3.5 alvern Panalytical锛圫pectris锛� Recent Development
11.4 Sygnature Discovery
11.4.1 Sygnature Discovery Company Details
11.4.2 Sygnature Discovery Business Overview
11.4.3 Sygnature Discovery Drug Discovery and Development Services Introduction
11.4.4 Sygnature Discovery Revenue in Drug Discovery and Development Services Business (2020-2025)
11.4.5 Sygnature Discovery Recent Development
11.5 RTI International
11.5.1 RTI International Company Details
11.5.2 RTI International Business Overview
11.5.3 RTI International Drug Discovery and Development Services Introduction
11.5.4 RTI International Revenue in Drug Discovery and Development Services Business (2020-2025)
11.5.5 RTI International Recent Development
11.6 Genesis Biotechnology Group
11.6.1 Genesis Biotechnology Group Company Details
11.6.2 Genesis Biotechnology Group Business Overview
11.6.3 Genesis Biotechnology Group Drug Discovery and Development Services Introduction
11.6.4 Genesis Biotechnology Group Revenue in Drug Discovery and Development Services Business (2020-2025)
11.6.5 Genesis Biotechnology Group Recent Development
11.7 Eurofins DiscoverX
11.7.1 Eurofins DiscoverX Company Details
11.7.2 Eurofins DiscoverX Business Overview
11.7.3 Eurofins DiscoverX Drug Discovery and Development Services Introduction
11.7.4 Eurofins DiscoverX Revenue in Drug Discovery and Development Services Business (2020-2025)
11.7.5 Eurofins DiscoverX Recent Development
11.8 Dalton Pharma Services
11.8.1 Dalton Pharma Services Company Details
11.8.2 Dalton Pharma Services Business Overview
11.8.3 Dalton Pharma Services Drug Discovery and Development Services Introduction
11.8.4 Dalton Pharma Services Revenue in Drug Discovery and Development Services Business (2020-2025)
11.8.5 Dalton Pharma Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

IQVIA
WuXi AppTec
alvern Panalytical锛圫pectris锛�
Sygnature Discovery
RTI International
Genesis Biotechnology Group
Eurofins DiscoverX
Dalton Pharma Services

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂